Price$3.28-0.48 (-12.77%)
01:30 PM07:45 PM
News · 26 weeks31+100%
2025-10-262026-04-19
Mix1890d
- Other8(44%)
- SEC Filings8(44%)
- Analyst1(6%)
- Earnings1(6%)
Latest news
25 items- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International MarketsNASDAQ | TSX: ACBEDMONTON, AB, April 15, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce it has acquired Safari Flower Company, an established EU GMP certified cannabis cultivator and manufacturer. Aggregate consideration is valued at $26.5 million, subject to customary adjustments, and inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions (the "Transaction"). "The acquisition of Safari Flower Company marks an impor
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive YearNASDAQ | TSX: ACBThe Globe and Mail's Report on Business Women Lead Here List acknowledges Aurora's commitment to inclusive leadership at the executive levelEDMONTON, AB, March 30, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian‑based leading global medical cannabis company, has been named on The Globe and Mail's 2026 Report on Business Women Lead Here list for the second consecutive year. The annual editorial benchmark recognizes publicly traded Canadian companies demonstrating strong executive‑level gender diversity, underscoring Aurora's continued commitment to inclusive leadership.
- PRAurora to Participate in the TD Cowen 46th Annual Health Care ConferenceNASDAQ | TSX: ACBCanada's Largest Global Medical Cannabis Company to Discuss Growth Strategy, Key Trends and Market OpportunitiesEDMONTON, AB, Feb. 17, 2026 /CNW/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, will participate in TD Cowen's 46th Annual Health Care Conference in Boston, MA. Simona King, Chief Financial Officer at Aurora, will take part in a fireside chat and one-on-one meetings with investors on March 2, 2026. Conference DetailsDATE: Monday, March 2, 2026TIME: 11:10am Eastern Time | 9:10am Mountain TimeW
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical CannabisNASDAQ | TSX: ACB EDMONTON, AB, Feb. 12, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the company will ring the Nasdaq closing bell on Wednesday, February 18, 2026, at the Nasdaq MarketSite in New York's Times Square. The ceremony will be led by Aurora's CEO and Executive Chairman, Miguel Martin, alongside a representative of the company's Board of Directors, executive leadership team and other employees. This e
- PRAurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New ZealandNASDAQ | TSX: ACB Launch reinforces Aurora's leadership position across key international markets EDMONTON, AB, Feb. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form SUPPL filed by Aurora Cannabis Inc.SUPPL - AURORA CANNABIS INC (0001683541) (Filer)
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering ProgramNASDAQ | TSX: ACB EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has filed a prospectus supplement establishing a new at-the-market offering program (the "ATM Program") that allows the Company to issue and sell up to U.S.$100 million of common shares in the capital of the Company (the "Common Shares") from treasury to the public, from time to time, at the Company's discretion. The Company intends to use the net proceeds from th
- PRAurora Cannabis Announces Fiscal 2026 Third Quarter ResultsNASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.
- PRAurora Launches New European Websites, Showcasing Science-Backed Cannabis LeadershipNASDAQ | TSX: ACB Launch of improved, localized websites underscores Aurora's long-term strategy for growth and engagement across key European medical markets EDMONTON, AB, Feb. 3, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of four brand new websites to support key European markets, continuing its investment in the region through a more focused, locally-relevant digital presence. The refreshed platforms are designed to better reflect Aurora's science-backed approach, manufacturing expertise, and brand strength, while improving engagement with healthcare professionals, partners, and prospect
- ANALYSTCanaccord Genuity initiated coverage on Aurora CannabisCanaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Cannabis to Host Third Quarter 2026 Investor Conference CallNASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 4, 2026 TIME: 8:00 a.m. Eastern Time |
- PRAurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis VarietiesNASDAQ | TSX: ACB European grant advances Aurora's unparalleled leadership in cannabis genetics, enhancing its position as a leading medical cannabis company EDMONTON, AB, Jan. 20, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announces that it has been granted community plant variety rights by the EU's Community Plant Variety Office for two of its proprietary cannabis varieties. This achievement further strengthens the company's intellectual property portfolio and reinforces its commitment to innovation and cannabis genetics excellence.
- SECSEC Form 6-K filed by Aurora Cannabis Inc.6-K - AURORA CANNABIS INC (0001683541) (Filer)
- PRAurora Achieves Significant Progress in Disease Resistance ResearchNASDAQ | TSX: ACB As a leading global medical cannabis company, advancements in breeding, testing and production trials for powdery mildew-resistant cultivars reinforce Aurora's leadership in cannabis science EDMONTON, AB, Jan. 14, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce significant progress in its powdery mildew (PM) resistance research, nearly one year after the company's breakthrough discovery of a novel source of genetic resistance against powdery mildew, PM2. Since
- PRAurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to PatientsNASDAQ | TSX: ACB Daily Special™ launch expands Aurora's leading portfolio of medical cannabis products available in the company's fastest growing market EDMONTON, AB, Dec. 18, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of Daily Special™, a new medical cannabis brand for the German market. Designed to offer reliable, high-quality flower at an accessible price point, the Daily Special brand is an exciting addition to Germany's rapidly growing medical cannabis sector, following record performance for the company.
- PRAurora Expands Leading Portfolio of High-Potency Medical Flower Products in PolandLatest Innovation Brings New Proprietary Cultivar to Polish Patients NASDAQ | TSX: ACB EDMONTON, AB, Dec. 11, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces the launch of Black Jelly, a proprietary cultivar, in Poland, expanding the company's portfolio of high-potency medical cannabis products in one of Europe's fastest-growing markets. Grown and manufactured in Aurora's Canadian GACP and EU-GMP certified facilities, Black Jelly joins Farm Gas and Sourdough under the Cannabis flos Aurora brand portfolio.